Keywords: Eli Lilly, Second-quarter financial results
Eli Lilly sees 2nd-qtr 2010 profits leap 16% on 9% revenue growth - toppping expectations; ups forecast
Article | 23 July 2010
US drug major Eli Lilly revealed yesterday that second-quarter 2010 net income rose to $1.3 billion, or $1.22 a share, from $1.2 billion, or $1.06 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
